Fran Gregory, PharmD, MBA has been named Vice President of Emerging Therapies for Cardinal Health.
In this role, she will be responsible for responsible for cell & gene therapies and biosimilars.
“Fran began her career initiating one of the largest specialty pharmacies in the country. She followed that accomplishment with bringing the first cell & gene therapy in the world to patients.
“Most recently, Fran developed and launched several of the most successful biosimilars in the US. She has a passion for complex, life-changing medicines and excels at developing and growing innovative business units. Fran is an industry expert in reimbursement, value-based pharmaceutical contracting, HEOR, and leading successful teams.”